Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism

Fig. 2

AVN-A decrease viability of MDA-MB-231 breast cancer cells in a time and concentration dependent manner. a MTT cell viability assay after treatment with DMSO 0.4% (vehicle) or AVN-A for 48 h at the indicated concentrations. b AVN-A treatment, 72 h. c AVN-A treatment, 96 h. Averages of a biological replicate done in triplicate; * indicates statistical significance difference from 0.4% DMSO negative control as determined by a t test at p < 0.05 level of significance, ** indicates significance level at p < 0.01, *** indicates significance at p < 0.001 level

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us